SG11201700530PA - Agent for improving brain function and agent for preventing or treating cognitive impairment - Google Patents

Agent for improving brain function and agent for preventing or treating cognitive impairment

Info

Publication number
SG11201700530PA
SG11201700530PA SG11201700530PA SG11201700530PA SG11201700530PA SG 11201700530P A SG11201700530P A SG 11201700530PA SG 11201700530P A SG11201700530P A SG 11201700530PA SG 11201700530P A SG11201700530P A SG 11201700530PA SG 11201700530P A SG11201700530P A SG 11201700530PA
Authority
SG
Singapore
Prior art keywords
agent
preventing
cognitive impairment
brain function
treating cognitive
Prior art date
Application number
SG11201700530PA
Other languages
English (en)
Inventor
Hiroshi Kunugi
Miho Ota
Junko Matsuo
Yoshitatsu Ichihara
Original Assignee
Food Science Inst Foundation
Nat Ct Neurology & Psychiatry
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Food Science Inst Foundation, Nat Ct Neurology & Psychiatry filed Critical Food Science Inst Foundation
Publication of SG11201700530PA publication Critical patent/SG11201700530PA/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/23—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
    • A23C9/00—Milk preparations; Milk powder or milk powder preparations
    • A23C9/16—Agglomerating or granulating milk powder; Making instant milk powder; Products obtained thereby
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/115—Fatty acids or derivatives thereof; Fats or oils
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/125—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives containing carbohydrate syrups; containing sugars; containing sugar alcohols; containing starch hydrolysates
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/19—Dairy proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7016—Disaccharides, e.g. lactose, lactulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/20—Milk; Whey; Colostrum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/01—Hydrolysed proteins; Derivatives thereof
    • A61K38/012—Hydrolysed proteins; Derivatives thereof from animals
    • A61K38/018—Hydrolysed proteins; Derivatives thereof from animals from milk
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A61K38/1722—Plasma globulins, lactoglobulins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/40—Transferrins, e.g. lactoferrins, ovotransferrins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2200/00—Function of food ingredients
    • A23V2200/30—Foods, ingredients or supplements having a functional effect on health
    • A23V2200/322—Foods, ingredients or supplements having a functional effect on health having an effect on the health of the nervous system or on mental function
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2250/00—Food ingredients
    • A23V2250/18—Lipids
    • A23V2250/194—Triglycerides
    • A23V2250/1944—Medium-chain triglycerides
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2250/00—Food ingredients
    • A23V2250/54—Proteins
    • A23V2250/542—Animal Protein
    • A23V2250/5424—Dairy protein
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Biomedical Technology (AREA)
  • Nutrition Science (AREA)
  • Mycology (AREA)
  • Molecular Biology (AREA)
  • Neurosurgery (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Neurology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Emergency Medicine (AREA)
  • Cell Biology (AREA)
  • Hospice & Palliative Care (AREA)
  • Developmental Biology & Embryology (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Psychiatry (AREA)
  • Virology (AREA)
  • Biotechnology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
SG11201700530PA 2014-07-23 2015-07-23 Agent for improving brain function and agent for preventing or treating cognitive impairment SG11201700530PA (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2014149990 2014-07-23
PCT/JP2015/070976 WO2016013617A1 (fr) 2014-07-23 2015-07-23 Agent d'amélioration de fonction cérébrale, et agent prophylactique ou thérapeutique pour dysfonctionnement cognitif

Publications (1)

Publication Number Publication Date
SG11201700530PA true SG11201700530PA (en) 2017-02-27

Family

ID=55163141

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11201700530PA SG11201700530PA (en) 2014-07-23 2015-07-23 Agent for improving brain function and agent for preventing or treating cognitive impairment

Country Status (8)

Country Link
US (2) US20180169052A1 (fr)
EP (1) EP3173089B1 (fr)
JP (1) JP6609555B2 (fr)
CN (1) CN106535919A (fr)
CA (1) CA2955915A1 (fr)
SG (1) SG11201700530PA (fr)
TW (1) TWI722992B (fr)
WO (1) WO2016013617A1 (fr)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6935994B2 (ja) * 2016-08-19 2021-09-15 株式会社明治 ケトン体生成促進用組成物
JP2018184369A (ja) * 2017-04-26 2018-11-22 株式会社明治 知的作業能力向上用組成物および認知能力向上用組成物
TW201919604A (zh) * 2017-07-26 2019-06-01 日商明治股份有限公司 酮體生成促進劑
KR20200132950A (ko) * 2018-03-15 2020-11-25 세레신 인코포레이티드 높은 약물 로딩의 중쇄 트리글리세라이드를 갖는 약학적 조성물 및 이와 관련된 방법
US11058139B2 (en) * 2018-07-03 2021-07-13 Kerri Ann Langhorne Recovery supplement for horses
BR112020024310A2 (pt) * 2018-07-10 2021-02-23 Société des Produits Nestlé S.A. formulações de tcm para aumentar a exposição à cetona e métodos para produzir e usar tais formulações
JP7011984B2 (ja) * 2018-07-13 2022-01-27 キリンホールディングス株式会社 注意機能および判断機能向上用組成物
IL268457B (en) 2019-08-04 2022-05-01 Omega 3 Galilee Ltd Oil suspension of edible solids and methods of preparation
CN111096455A (zh) * 2020-01-15 2020-05-05 浙江科技学院 一种抗老年痴呆的全营养配方食品

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3486778B2 (ja) * 1993-04-02 2004-01-13 三菱ウェルファーマ株式会社 アルツハイマー病予防治療剤
EP1090636A1 (fr) * 1999-09-13 2001-04-11 Société des Produits Nestlé S.A. Régime à haute proportion de lipides
CA2632550C (fr) * 2005-12-15 2017-07-25 Nestec S.A. Triglycerides a chaine moyenne pour la preservation de la fonction cognitive
HUE040002T2 (hu) * 2006-04-03 2019-02-28 Accera Inc Ketogén vegyületek alkalmazása korfüggõ memóriazavar kezelésére
WO2009002145A1 (fr) * 2007-06-26 2008-12-31 N.V. Nutricia Composition lipidique destinée à améliorer l'activité cérébrale
ES2478869T3 (es) * 2010-01-29 2014-07-23 N.V. Nutricia Composición nutricional enteral líquida adecuada para alimentación por sonda
WO2014027022A1 (fr) * 2012-08-14 2014-02-20 Nestec S.A. Compositions diététiques pour le traitement de malnutrition, de maladies neurologiques et de maladies métaboliques

Also Published As

Publication number Publication date
EP3173089C0 (fr) 2023-10-25
TW201613632A (en) 2016-04-16
US20180169052A1 (en) 2018-06-21
EP3173089A1 (fr) 2017-05-31
CA2955915A1 (fr) 2016-01-28
US20200108040A1 (en) 2020-04-09
CN106535919A (zh) 2017-03-22
WO2016013617A1 (fr) 2016-01-28
EP3173089B1 (fr) 2023-10-25
JPWO2016013617A1 (ja) 2017-05-25
TWI722992B (zh) 2021-04-01
JP6609555B2 (ja) 2019-11-20
EP3173089A4 (fr) 2018-04-04

Similar Documents

Publication Publication Date Title
IL262225A (en) Methods for monitoring and treating cancer
IL278018A (en) Methods for the treatment or prevention of ophthalmological conditions
ZA201705673B (en) Methods for treating skin
PL3466435T3 (pl) Środek poprawiający funkcjonowanie mózgu
SG11201700530PA (en) Agent for improving brain function and agent for preventing or treating cognitive impairment
ZA201700416B (en) Methods for treating or preventing ophthalmological conditions
IL262223A (en) Methods for monitoring and treating cancer
HK1261918A1 (zh) 預防和/或治療與衰老有關的認知障礙和神經炎症的方法
IL262825A (en) Tetrahydropyridine and tetrahydropyrimidine substances, preparations containing them and their use for pain treatment
HK1254362A1 (zh) 用於治療認知損害的苯並二氮雜環庚三烯衍生物、組合物和方法
IL250213A0 (en) A method for treating cognitive or emotional impairment related to radiotherapy and chemotherapy with cannabinoids
HK1244211A1 (zh) 治療、預防或降低皮膚感染風險的方法
HK1211441A1 (en) Methods for treating, preventing, or reducing neuroinflammation or cognitive impairment
IL255012A0 (en) Preparations and methods for treating skin conditions
GB201617715D0 (en) Methods for the treatment and prevention of ebola
GB201617591D0 (en) Methods for the treatment and prevention of ebola
GB201617590D0 (en) Methods for the treatment and prevention of ebola
SG11201804140PA (en) Acidic-gas treating agent and acidic-gas treating method
GB201518489D0 (en) Methods for the treatment and prevention of ebola
GB201415876D0 (en) Methods for the treatment and prevention of Ebola